# 21 U.S.C. 360bbb-5 Critical Path Public-Private Partnerships

21 U.S.C. 360bbb-5 Critical Path Public-Private Partnerships, “Critical Path Public-Private Partnerships”, is a U.S. Code section of [Part E—General Provisions Relating to Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb9b-72d3-b67d-4d99ebbaa239); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f06c-cd48-7222-a8aa-c5cbdc8ff75f>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f06c-cb65-7672-8fda-c39517ff08c0) › [Chapter 9—Federal Food, Drug, and Cosmetic Act](https://ontology.bommaritollc.com/id/01a0f06c-cb91-72e0-858b-060e8c845f23) › [Subchapter V—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb96-7040-b454-c8f18e0e95cb) › [Part E—General Provisions Relating to Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb9b-72d3-b67d-4d99ebbaa239)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [usc-section 21 U.S.C. 360bbb-5](https://ontology.bommaritollc.com/id/01a0f06c-cd49-7776-a7f9-319ddebf383e)
- `eli:cites`:
  - [20 U.S.C. 1001 General definition of institution of higher education](https://ontology.bommaritollc.com/id/01a0f06c-0fb4-7451-a666-0a2862bda4f3)
  - [26 U.S.C. 501 Exemption from tax on corporations, certain trusts, etc.](https://ontology.bommaritollc.com/id/01a0f071-2045-73e4-b918-7af09614eb5f)
  - [42 U.S.C. 262 Regulation of biological products](https://ontology.bommaritollc.com/id/01a0f07c-d9ca-7203-a1d8-2d79c0329140)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partE-sec360bbb-5](https://ontology.bommaritollc.com/id/01a0f06c-cd48-7222-a8aa-c5cac5e45cc3)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f06c-d167-7343-a24f-0233cc4df3ec)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d2-2d97-72e9-8217-8a6025148ad4)
  - [evidence from https://www.govinfo.gov/link/uscode/21/360bbb-5?type=usc&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f15-fe3e-73b8-8a1a-9a6b4c0c5e7a)
- `schema:isPartOf`: [Part E—General Provisions Relating to Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb9b-72d3-b67d-4d99ebbaa239)
- `schema:legislationIdentifier`: 21 U.S.C. 360bbb-5
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [U.S. Code section](https://ontology.bommaritollc.com/vocab/leg/uscSection)
- `schema:name`: Critical Path Public-Private Partnerships
- `schema:url`: [https://www.govinfo.gov/link/uscode/21/360bbb-5?type=usc&year=mostrecent&link-type=details](https://www.govinfo.gov/link/uscode/21/360bbb-5?type=usc&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 U.S.C. 360bbb-5 Critical Path Public-Private Partnerships

## Elsewhere

- [Official page](https://www.govinfo.gov/link/uscode/21/360bbb-5?type=usc&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partE-sec360bbb-5) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Amended by (5; `eli:amends`):
  - [Pub. L. 112-144](https://ontology.bommaritollc.com/id/01a0f06a-a3b6-70e5-8204-79bb2755f506)
  - [Pub. L. 115-52](https://ontology.bommaritollc.com/id/01a0f06c-d2f5-7295-8628-c43a73a54615)
  - [Pub. L. 117-180](https://ontology.bommaritollc.com/id/01a0f06a-a3dc-779c-933c-4e4b12b48124)
  - [Pub. L. 117-229](https://ontology.bommaritollc.com/id/01a0ee1d-97fa-71e5-9133-25d78f05040d)
  - [Pub. L. 117-328](https://ontology.bommaritollc.com/id/01a0edf4-a3b3-73ad-8a5b-366dfc33cea1)
- Cited by (1; `eli:cites`):
  - [21 U.S.C. 379dd-2 Activities of the Food and Drug Administration](https://ontology.bommaritollc.com/id/01a0f06c-cdf4-70d5-9883-654f7d41f4be)
- Its changes, from (1; `eli:changes`):
  - [Pub. L. 110-85](https://ontology.bommaritollc.com/id/01a0f06c-d2ac-7439-ab06-bdf3d920772b)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f06c-cd48-7222-a8aa-c5cbdc8ff75f.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f06c-cd48-7222-a8aa-c5cbdc8ff75f.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f06c-cd48-7222-a8aa-c5cbdc8ff75f.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f06c-cd48-7222-a8aa-c5cbdc8ff75f)
Cite as: 21 U.S.C. 360bbb-5 Critical Path Public-Private Partnerships. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-cd48-7222-a8aa-c5cbdc8ff75f
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
